Japanese Earnings Roundup: Shionogi Rebounds From U.S. Acquisition Woes With C&O Pharmaceutical For China; Astellas Ponders Mirabegron's Reproductive Warning

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.